The Saudi government sought to establish a national public health agency as a critical component of its efforts to transform the country’s entire health system.
Case Study
Leveraging External Partnerships to Maximize the Value of a Top-5 Pharma’s Portfolio
In the face of constrained R&D budgets, a top-5 pharmaceutical company needed support to develop a transformative, corporate-wide strategy to assess and secure external funding.
Delivering on a New Mandate to Strengthen Dementia Research, Care and Community Support
The Alzheimer Society of Canada—the national body of a federation of dozens of provincial societies and regional chapters—needed a strategy to deliver a newly-approved mandate.
Developing a Therapeutic Vaccine of Greatest Value to Patients and Systems
A top-5 pharmaceutical company sought the perspectives of payers in the US and major EU markets to ensure that the value of an innovative vaccine would ultimately be recognized by health systems.
Attracting $100M in Government Support for the Ontario Brain Institute
The Ontario Brain Institute (OBI) needed to define its strategic direction and articulate its value to policymakers to ensure continued government support for brain research.
Inspiring Urgency Needed to Tackle Alzheimer’s Disease
A top-5 pharmaceutical company needed to prepare decision-makers for the patient and health system impact of disease-modifying therapies and diagnostic biomarkers for Alzheimer’s disease.
Uncovering Risks and Forecasting Performance of a Royalty Portfolio to Guide Investment Decisions
A large institutional investment firm engaged Shift Health to evaluate the products in a portfolio of pharma royalties it had an opportunity to acquire.
Putting Health Research on the Map in a Resource-based Economy
The Saudi Government aimed to create a national health research agency to strengthen the research and innovation ecosystem, support a learning healthcare system and diversify the Kingdom’s knowledge economy.
Uniting a Country Around a Single Vision for Cancer Research
Cancer research stakeholders across Canada recognized the need for a unifying vision that would inspire collective action and prepare Canada for leadership in a rapidly evolving cancer research landscape.